$34.23
0.190.56%
At close: -
$34.26
0.030.09%
After Hours: 7:37 PM EDT
Comments
Loading...
Keurig Dr Pepper Analyst Ratings and Price Targets | NASDAQ:KDP | Benzinga
Keurig Dr Pepper Inc has a consensus price target of $38.9 based on the ratings of 20 analysts. The high is $42 issued by HSBC on April 25, 2025. The low is $34 issued by Truist Securities on June 17, 2024. The 3 most-recent analyst ratings were released by Barclays, HSBC, and RBC Capital on April 28, 2025, April 25, 2025, and April 22, 2025, respectively. With an average price target of $40.67 between Barclays, HSBC, and RBC Capital, there's an implied 18.69% upside for Keurig Dr Pepper Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
HSBC
RBC Capital
UBS
Argus Research
1calculated from analyst ratings
Analyst Ratings for Keurig Dr Pepper
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/28/2025 | Buy Now | 10.91% | Barclays | Lauren Lieberman64% | $37 → $38 | Maintains | Overweight | Get Alert |
| 04/25/2025 | Buy Now | 22.58% | HSBC | Rajesh Kumar67% | $36 → $42 | Upgrade | Hold → Buy | Get Alert |
| 04/22/2025 | Buy Now | 22.58% | RBC Capital | Nik Modi52% | $42 → $42 | Reiterates | Outperform → Outperform | Get Alert |
| 04/17/2025 | Buy Now | 22.58% | UBS | Sean King67% | $40 → $42 | Maintains | Buy | Get Alert |
| 04/16/2025 | Buy Now | 16.75% | Argus Research | Stephen Biggar71% | → $40 | Initiates | → Buy | Get Alert |
| 04/09/2025 | Buy Now | 16.75% | Piper Sandler | Mike Lavery57% | $35 → $40 | Upgrade | Neutral → Overweight | Get Alert |
| 04/01/2025 | Buy Now | 16.75% | Morgan Stanley | Dara Mohsenian73% | $38 → $40 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/27/2025 | Buy Now | 13.83% | Barclays | Lauren Lieberman64% | $36 → $39 | Maintains | Overweight | Get Alert |
| 02/26/2025 | Buy Now | 16.75% | JP Morgan | Andrea Teixeira59% | $37 → $40 | Maintains | Overweight | Get Alert |
| 02/26/2025 | Buy Now | 10.91% | Morgan Stanley | Dara Mohsenian73% | $36 → $38 | Maintains | Equal-Weight | Get Alert |
| 01/17/2025 | Buy Now | 5.07% | Barclays | Lauren Lieberman64% | $39 → $36 | Maintains | Overweight | Get Alert |
| 01/16/2025 | Buy Now | 7.99% | UBS | Sean King67% | $42 → $37 | Maintains | Buy | Get Alert |
| 01/08/2025 | Buy Now | 5.07% | TD Cowen | Vivien Azer58% | $39 → $36 | Maintains | Hold | Get Alert |
| 01/07/2025 | Buy Now | 16.75% | Wells Fargo | Chris Carey62% | $42 → $40 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | 2.15% | Piper Sandler | Mike Lavery57% | → $35 | Initiates | → Neutral | Get Alert |
| 12/12/2024 | Buy Now | 13.83% | Deutsche Bank | Steve Powers70% | $37 → $39 | Upgrade | Hold → Buy | Get Alert |
| 10/28/2024 | Buy Now | 13.83% | Barclays | Lauren Lieberman64% | $41 → $39 | Maintains | Overweight | Get Alert |
| 10/25/2024 | Buy Now | 16.75% | Citigroup | Filippo Falorni52% | $43 → $40 | Maintains | Buy | Get Alert |
| 10/25/2024 | Buy Now | 22.58% | RBC Capital | Nik Modi52% | $41 → $42 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 19.67% | Jefferies | Kaumil Gajrawala52% | $42 → $41 | Maintains | Buy | Get Alert |
| 10/25/2024 | Buy Now | 16.75% | JP Morgan | Andrea Teixeira59% | $41 → $40 | Maintains | Overweight | Get Alert |
| 10/25/2024 | Buy Now | 22.58% | Wells Fargo | Chris Carey62% | $43 → $42 | Maintains | Overweight | Get Alert |
| 10/16/2024 | Buy Now | 19.67% | JP Morgan | Andrea Teixeira59% | $38 → $41 | Maintains | Overweight | Get Alert |
| 10/11/2024 | Buy Now | 19.67% | Barclays | Lauren Lieberman64% | $37 → $41 | Maintains | Overweight | Get Alert |
| 09/26/2024 | Buy Now | 16.75% | TD Cowen | Vivien Azer58% | $35 → $40 | Maintains | Hold | Get Alert |
| 09/23/2024 | Buy Now | 7.99% | Deutsche Bank | Steve Powers70% | $36 → $37 | Maintains | Hold | Get Alert |
| 09/23/2024 | Buy Now | 25.5% | Citigroup | Filippo Falorni52% | $36 → $43 | Upgrade | Neutral → Buy | Get Alert |
| 07/26/2024 | Buy Now | 19.67% | RBC Capital | Nik Modi52% | $41 → $41 | Reiterates | Outperform → Outperform | Get Alert |
| 07/19/2024 | Buy Now | 7.99% | Barclays | Lauren Lieberman64% | $38 → $37 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | 5.07% | JP Morgan | Andrea Teixeira59% | $37 → $36 | Maintains | Overweight | Get Alert |
| 06/24/2024 | Buy Now | 5.07% | Exane BNP Paribas | Kevin Grundy56% | → $36 | Initiates | → Neutral | Get Alert |
| 06/17/2024 | Buy Now | -0.76% | Truist Securities | Bill Chappell47% | $27 → $34 | Upgrade | Sell → Hold | Get Alert |
| 06/10/2024 | Buy Now | 16.75% | UBS | Sean King67% | $39 → $40 | Maintains | Buy | Get Alert |
| 06/05/2024 | Buy Now | 19.67% | Wells Fargo | Chris Carey62% | $39 → $41 | Maintains | Overweight | Get Alert |
| 04/29/2024 | Buy Now | 10.91% | Barclays | Lauren Lieberman64% | $36 → $38 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 2.15% | TD Cowen | Vivien Azer58% | $32 → $35 | Maintains | Hold | Get Alert |
| 04/12/2024 | Buy Now | 5.07% | Barclays | Lauren Lieberman64% | $32 → $36 | Maintains | Overweight | Get Alert |
| 03/27/2024 | Buy Now | 2.15% | Jefferies | Kaumil Gajrawala52% | $37 → $35 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | -6.6% | Barclays | Lauren Lieberman64% | $34 → $32 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | -0.76% | Morgan Stanley | Dara Mohsenian73% | $37 → $34 | Maintains | Equal-Weight | Get Alert |
| 02/26/2024 | Buy Now | 2.15% | Wedbush | Gerald Pascarelli46% | $37 → $35 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 19.67% | RBC Capital | Nik Modi52% | $42 → $41 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | -0.76% | Barclays | Lauren Lieberman64% | $37 → $34 | Maintains | Overweight | Get Alert |
| 01/16/2024 | Buy Now | 7.99% | Barclays | Lauren Lieberman64% | $36 → $37 | Maintains | Overweight | Get Alert |
| 01/03/2024 | Buy Now | 7.99% | Morgan Stanley | Dara Mohsenian73% | → $37 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/22/2023 | Buy Now | 7.99% | HSBC | Carlos Laboy52% | → $37 | Initiates | → Hold | Get Alert |
| 11/13/2023 | Buy Now | 13.83% | Jefferies | Kaumil Gajrawala52% | → $39 | Initiates | → Buy | Get Alert |
| 10/30/2023 | Buy Now | 5.07% | Barclays | Lauren Lieberman64% | $34 → $36 | Maintains | Overweight | Get Alert |
| 10/27/2023 | Buy Now | 7.99% | Morgan Stanley | Dara Mohsenian73% | $39 → $37 | Maintains | Overweight | Get Alert |
| 10/12/2023 | Buy Now | -0.76% | Barclays | Lauren Lieberman64% | $40 → $34 | Maintains | Overweight | Get Alert |
| 10/12/2023 | Buy Now | 7.99% | Bernstein | Callum Elliott60% | $40 → $37 | Maintains | Outperform | Get Alert |
| 10/11/2023 | Buy Now | -3.68% | Citigroup | Filippo Falorni52% | $37 → $33 | Maintains | Neutral | Get Alert |
| 08/16/2023 | Buy Now | 22.58% | UBS | Peter Grom56% | $37 → $42 | Upgrade | Neutral → Buy | Get Alert |
| 07/28/2023 | Buy Now | 16.75% | Barclays | Lauren Lieberman64% | $37 → $40 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | 7.99% | Wedbush | Gerald Pascarelli46% | $40 → $37 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | 2.15% | Citigroup | Filippo Falorni52% | $37 → $35 | Maintains | Neutral | Get Alert |
| 07/06/2023 | Buy Now | 7.99% | Morgan Stanley | Dara Mohsenian73% | → $37 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/01/2023 | Buy Now | 22.58% | RBC Capital | Nik Modi52% | → $42 | Reiterates | → Outperform | Get Alert |
| 05/01/2023 | Buy Now | 7.99% | Barclays | Lauren Lieberman64% | $42 → $37 | Maintains | Overweight | Get Alert |
| 04/28/2023 | Buy Now | 16.75% | Wedbush | Gerald Pascarelli46% | $43 → $40 | Maintains | Outperform | Get Alert |
| 04/28/2023 | Buy Now | 7.99% | Barclays | Lauren Lieberman64% | $42 → $37 | Maintains | Overweight | Get Alert |
| 04/18/2023 | Buy Now | 19.67% | JP Morgan | Andrea Teixeira59% | $40 → $41 | Maintains | Overweight | Get Alert |
| 04/14/2023 | Buy Now | 22.58% | Barclays | Lauren Lieberman64% | $40 → $42 | Maintains | Overweight | Get Alert |
| 03/20/2023 | Buy Now | 5.07% | Deutsche Bank | Steve Powers70% | $38 → $36 | Maintains | Hold | Get Alert |
| 02/27/2023 | Buy Now | 16.75% | Barclays | Lauren Lieberman64% | $45 → $40 | Maintains | Overweight | Get Alert |
| 02/17/2023 | Buy Now | 7.99% | Citigroup | Filippo Falorni52% | → $37 | Initiates | → Neutral | Get Alert |
| 01/26/2023 | Buy Now | 19.67% | JP Morgan | Andrea Teixeira59% | $40 → $41 | Maintains | Overweight | Get Alert |
| 01/03/2023 | Buy Now | 16.75% | Wells Fargo | Chris Carey62% | $42 → $40 | Maintains | Overweight | Get Alert |
| 12/06/2022 | Buy Now | 13.83% | Deutsche Bank | Steve Powers70% | $38 → $39 | Maintains | Hold | Get Alert |
| 10/31/2022 | Buy Now | 31.34% | Barclays | Lauren Lieberman64% | $41 → $45 | Maintains | Overweight | Get Alert |
| 10/31/2022 | Buy Now | -12.44% | Truist Securities | Bill Chappell47% | → $30 | Downgrade | Hold → Sell | Get Alert |
| 10/28/2022 | Buy Now | 22.58% | Wells Fargo | Chris Carey62% | $41 → $42 | Maintains | Overweight | Get Alert |
| 10/17/2022 | Buy Now | 10.91% | Deutsche Bank | Steve Powers70% | $37 → $38 | Maintains | Hold | Get Alert |
| 10/11/2022 | Buy Now | 25.5% | Wedbush | Gerald Pascarelli46% | → $43 | Initiates | → Outperform | Get Alert |
| 10/03/2022 | Buy Now | 19.67% | Wells Fargo | Chris Carey62% | $43 → $41 | Maintains | Overweight | Get Alert |
| 09/27/2022 | Buy Now | 7.99% | Goldman Sachs | Bonnie Herzog69% | $39 → $37 | Downgrade | Buy → Neutral | Get Alert |
| 08/01/2022 | Buy Now | 19.67% | UBS | Peter Grom56% | $38 → $41 | Maintains | Neutral | Get Alert |
| 07/20/2022 | Buy Now | 22.58% | JP Morgan | Andrea Teixeira59% | $44 → $42 | Maintains | Overweight | Get Alert |
| 06/21/2022 | Buy Now | 10.91% | UBS | Peter Grom56% | $42 → $38 | Downgrade | Buy → Neutral | Get Alert |
| 05/02/2022 | Buy Now | 34.26% | Barclays | Lauren Lieberman64% | $44 → $46 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Keurig Dr Pepper (KDP) stock?
The latest price target for Keurig Dr Pepper (NASDAQ:KDP) was reported by Barclays on April 28, 2025. The analyst firm set a price target for $38.00 expecting KDP to rise to within 12 months (a possible 10.91% upside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Keurig Dr Pepper (KDP)?
The latest analyst rating for Keurig Dr Pepper (NASDAQ:KDP) was provided by Barclays, and Keurig Dr Pepper maintained their overweight rating.
When was the last upgrade for Keurig Dr Pepper (KDP)?
The last upgrade for Keurig Dr Pepper Inc happened on April 25, 2025 when HSBC raised their price target to $42. HSBC previously had a hold for Keurig Dr Pepper Inc.
When was the last downgrade for Keurig Dr Pepper (KDP)?
The last downgrade for Keurig Dr Pepper Inc happened on January 3, 2024 when Morgan Stanley changed their price target from N/A to $37 for Keurig Dr Pepper Inc.
When is the next analyst rating going to be posted or updated for Keurig Dr Pepper (KDP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Keurig Dr Pepper, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Keurig Dr Pepper was filed on April 28, 2025 so you should expect the next rating to be made available sometime around April 28, 2026.
Is the Analyst Rating Keurig Dr Pepper (KDP) correct?
While ratings are subjective and will change, the latest Keurig Dr Pepper (KDP) rating was a maintained with a price target of $37.00 to $38.00. The current price Keurig Dr Pepper (KDP) is trading at is $34.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
